IntegraGen Receives $2.4M from French Investment Firm | GenomeWeb

NEW YORK (GenomeWeb News) – Molecular diagnostics firm IntegraGen said on Thursday it has received €2 million ($2.4 million) in financing from funds managed by French private investment firm A Plus Finance.

The funds will go toward the continued development of genetic tests for colorectal cancer and liver cancer, Integragen, also based in France, said, and to accelerate R&D and commercialization efforts directed at molecular diagnostics for autism.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.